DCTH Stock Summary and Trading Ideas (Delcath Systems | NASDAQ:DCTH)

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

What symbol and exchange does Delcath Systems shares trade?

Delcath Systems trades on the NASDAQ stock market under the symbol DCTH.

What is Delcath Systems stock price doing today?

As of September 11, 2026, DCTH stock price climbed to $15.91 with 303,345 million shares trading.

What is Delcath Systems's Beta?

DCTH has a beta of 1.47, meaning it tends to be more sensitive to market movements. DCTH has a correlation of 0.15 to the broad based SPY ETF.

How much is Delcath Systems worth?

DCTH has a market cap of $552.06 million. This is considered a Small Cap stock.

How much money does Delcath Systems make?

Last quarter Delcath Systems reported $29 million in Revenue and $.07 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.17.

What is the highest and lowest price Delcath Systems traded in the last 3 year period?

In the last 3 years, DCTH traded as high as $18.23 and as low as $2.25.

What are the top ETFs holding Delcath Systems?

The top ETF exchange traded funds that DCTH belongs to (by Net Assets): VTI, VXF, VTWO, DFMC, DFAS.

Is Delcath Systems (DCTH) a good investment?

DCTH has outperformed the market in the last year with a return of +42.9%, while the SPY ETF gained +17.4%. In the last 3 month period, DCTH beat the market returning +35.2%, while SPY returned +3.9%. However, in the most recent 2 weeks DCTH has underperformed the stock market by returning -2.6%, while SPY returned -0.7%.

What are the support and resistance levels for Delcath Systems (DCTH)?

DCTH support price is $15.52 and resistance is $16.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DCTH shares will trade within this expected range on the day.